graph Evidence gap map comparisons
ipilimumab based treatmentanti-PD-(L)1
ipilimumab alone pembrolizumab based treatment
Comparator:  vs placebo;   vs chemotherapy; 
Risk of bias:  low;   some concerns;   high;  NA;